Home > Boards > US Listed > Biotechs > BIONDVAX PHARMACUETICALS LTD (BVXV)

Did someone get the memo?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Spideyboy Member Profile
 
Followed By 12
Posts 838
Boards Moderated 0
Alias Born 04/07/08
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/1/2020 8:20:36 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/1/2020 6:32:00 AM
Last of 12,400 Participants Completes Final Visit in BiondVax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial PR Newswire (US) - 7/1/2020 6:00:00 AM
BiondVax Announces First Quarter 2020 Financial Results PR Newswire (US) - 6/30/2020 4:01:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/22/2020 1:37:36 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/12/2020 8:11:32 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 6/12/2020 8:04:57 AM
BiondVax Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update PR Newswire (US) - 6/12/2020 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/10/2020 7:48:38 AM
NIH Report on Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Concludes Both Primary Endpoin... PR Newswire (US) - 6/10/2020 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/20/2020 7:44:36 AM
BiondVax Announces Receipt of $4.2 Million Through Exercise of Warrants PR Newswire (US) - 5/20/2020 6:30:00 AM
Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... Edgar (US Regulatory) - 5/13/2020 4:34:19 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/4/2020 10:48:44 AM
BiondVax Announces Upcoming Expiration of Public Warrants PR Newswire (US) - 5/4/2020 6:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/30/2020 9:40:42 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/24/2020 4:28:59 PM
New Directors Elected to BiondVax's Board of Directors PR Newswire (US) - 3/24/2020 4:01:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2020 1:06:02 PM
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial PR Newswire (US) - 3/19/2020 7:15:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/25/2020 12:42:30 PM
Amended Report of Foreign Issuer (6-k/a) Edgar (US Regulatory) - 2/10/2020 5:22:43 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/10/2020 11:15:24 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/5/2020 3:25:39 PM
Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Va... PR Newswire (US) - 2/5/2020 1:00:00 PM
Spideyboy   Friday, 05/08/20 03:06:22 AM
Re: None
Post # of 373 
Did someone get the memo?

I'm still looking for at least a 30-40% drop from here to get in. NIAID data probably in a month, but seems the conclusion of that data is already in.

That said, they have money at the moment to get to Q42020 when full results are due out, but will need more cash before that.

Curious how much they would get from the due warrants. Looked at the SEC filings, but still not sure, how much would be received. Do you have any idea on the range?

From here I'm seeing: "1,910,000 ADSs at an offering price of $5.00" which could mean an additional 9,555,500 dollars come in, but on their latest 6k they show Warrants at 1,984,000 dollars. That is a significant difference.
https://www.sec.gov/Archives/edgar/data/1611747/000121390015003785/f6k051515ex99i_biondvax.htm

If it is that 1,910,000 @5USD, then while the cash would be good, that would be very dilutional adding 20% to the shares outstanding. And the price differential of 15.86 to 5 is huge. If the underwriters know the product can't do anything for Covid, there could be a sell-off?

Personally hoping in due time pre-Q4 that this goes down to 9USD per share. Sorry Midas! :)



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist